big data ieee

Cloud DX's Chief Medical Officer Joins IEEE SA Telehealth Working Groups and Executive Team Update

News in Summary

  • Dr. Sonny Kohli, Cloud DX's chief medical officer and a critical care physician at Oakville Trafalgar Memorial Hospital, will advise the IEEE SA Telehealth IC Working Groups on establishing world-wide standards for telehealth and virtual care.
  • Government regulators, including Health Canada and the US FDA, often use IEEE standards as a requirement when approving new technologies for sale.
  • The chance to guide the development of international industry standards is another example of Cloud DX's acknowledged innovation and thought leadership in the field of virtual care.
  • Cloud DX CFO Stephanie Bird is transitioning out of Cloud DX effective Sept 30, 2021 to pursue a new opportunity.

Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care and remote patient monitoring solutions is pleased to announce that the company's Chief Medical Officer, Dr. Sonny Kohli has joined the IEEE SA Telehealth IC Working Groups, a new IEEE industrial connections program developing technical standards for novel telehealth technologies

As a global community the IEEE SA Telehealth IC working group will seek to create internationally applicable standards for telehealth and virtual care adoption. These standards will then be used by regulatory agencies like Health Canada and the US FDA to vet and approve the innovative new technologies to come.

The chance to influence and inform the creation of global standards will allow Cloud DX to have an even greater impact on the delivery of virtual care around the world.

"I am honoured to contribute to this important IEEE program and I look forward to sharing with this prestigious international working group the lessons we've learned at Cloud DX," stated Dr. Sonny Kohli, Chief Medical Officer, Cloud DX. "Being asked to participate in efforts to standardize digital healthcare is a testament to the industry's perception of Cloud DX as a leader in remote care. Clients that value excellence view this as one of our differentiators in the marketplace."

Dr. Keith Thompson, Chief Medical Officer at iTelemed and an IEEE SA telehealth IC working group member, adds "We are pleased to have Dr. Kohli join us in the IEEE SA Telehealth IC Working Groups. We need input from industry leaders already disrupting this space including professionals like Dr. Kohli who are passionate about making health care equitable around the world. Cloud DX has been on an incredible trajectory of growth given the accelerated interest in RPM systems during COVID. Sonny has been an inspiration for me personally and it is truly a milestone for our IEEE SA IC team to be able to work alongside him as we create the future standards for telehealth adoption".

Executive Team Update

CFO Stephanie Bird has elected to leave the company for a new opportunity with a private Toronto-based company, effective September 30, 2021. Cloud DX wishes to thank Ms. Bird for all her incredible hard work as we completed our go-public process in 2021, we wish her every success in her new role and we are pleased to work with her on an orderly transition. The company is currently engaged in a selection process to choose a new CFO on or before October 1, 2021.

About Cloud DX

Accelerating virtual healthcare's future,Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist and one of "Canada's Ten Most Prominent Telehealth Providers."

About IEEE SA

The Institute of Electrical and Electronics Engineers Standards Association (IEEE SA) is an operating unit within IEEE that develops global standards in a broad range of industries, including power and energy, artificial intelligence systems, internet of things, consumer technology and consumer electronics, biomedical and health care, information technology, robotics, telecommunication, home automation, automotive, transportation, nanotechnology, and many more. IEEE SA is not a body formally authorized by any government, but rather a community that provides a neutral platform that unites communities for standards development and technological innovation and is independent of any government oversight. IEEE SA develops standards that are consensus-based and offer balance, openness, and fair procedures. Technical experts from all over the world participate in the development of IEEE standards.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries, please contact:

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/661816/Cloud-DXs-Chief-Medical-Officer-Joins-IEEE-SA-Telehealth-Working-Groups-and-Executive-Team-Update

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less

Latest Press Releases

Related News

×